Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: eFFECTOR Therapeutics Inc Reports Q3 Diluted Loss Per Share Of $0.23

Nov 7 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * EFFECTOR THERAPEUTICS INC - QTRLY DILUTED LOSS PER SHARE
$0.23

Source text for Eikon:  ID:nGNX7szRkW 
Further company coverage:  EFTR.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news